If this CP is actually for funding new NPs aimed at prostate cancer etc., that is quite disappointing. The company needs to focus on success in their first trial. If the NPs are not safe, then what's the point of investigating new indications?
I sold a chunk of my holdings with the rise in share price recently, but will continue to hold a smaller chunk through trials and hopefully to positive results. I hope that I come to regret this in the future, but it was hard not to take profits.
If this CP is actually for funding new NPs aimed at prostate...
Add IBX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.677M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10941 | 8.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.5¢ | 305 | 1 |
View Market Depth
| Last trade - 16.12pm 09/07/2024 (20 minute delay) ? |
| IBX (ASX) Chart |
Day chart unavailable